News
Our work in News
-
Study Finds More Than 9 Million Excess Life Years Lost During COVID Pandemic
Black and Hispanic persons have experienced a disproportionate number of life-years lost.
Categorized in -
Erin Trish Appointed Co-Director of USC Schaeffer Center
Erin Trish, a health economist whose work focuses on the intersection of public policy and healthcare markets, has been named co-director of the Schaeffer Center.
-
NAS Report Outlines Priorities for the Next Ten Years of Alzheimer’s Research
Julie Zissimopoulos participated on the committee tasked with developing the research agenda.
-
Risk of Losing Cash Reward Strongly Impacts Exercise Habit
Researchers found adults were incentivized to exercise more often for the same anticipated cash reward simply by changing how the reward is delivered.
Categorized in -
USC Research Shows Costco Beats Medicare in Generic Drug Savings Nearly 50% of the Time
Intermediaries negotiate good prices, but lack incentives to pass savings to beneficiaries and taxpayers.
Categorized in -
Experts at Schaeffer-Aspen Webinar Discuss Modernizing Health Technology Assessment in the U.S.
The U.S. does not have a coordinated process to evaluate the effectiveness and value of new devices, medicines or procedures. Schaeffer Center and the Aspen Institute hosted a panel discussion on the viability of an Institute of Health Technology Assessment.
-
Precision Medicine: Moving Theory into Practice
Over a four-part webinar series, Schaeffer Center will bring together experts to discuss how we can move precision medicine from theory to practice.
-
USC Study Finds When Medicare Chips in for Hepatitis C Treatment for Medicaid Patients, Everyone Wins
A Medicaid-Medicare partnership could cover lifesaving hepatitis C medications — and still save $1 to $1.1 billion over 25 years
Categorized in -
New Schaeffer Center White Paper Explains Complicated Relationship Between FDA Approvals and Future Innovation
The relationship between approvals and future innovation is unclear at best. As such, the FDA should continue to base its decisions solely on safety and efficacy, rather than speculative long-term innovation effects.
Categorized in -
Roybal Fellow Sparks Winning Nudge to Increase Vaccine Uptake
Jehan Sparks helped design the top-performing “nudge” which resulted in an 11% increase in the rate of flu shot vaccinations.